decrease morbidity and to improve quality of life for adult survivors of cancer. The Panel will draft guidelines in the following areas: cardiovascular disease; hormone replacement therapy; osteoporosis; sexual dysfunction; second malignancies; neurocognitive dysfunction; psychosocial disease.

  • Cancer Quality Alliance: In response to IOM’s call for public/private partnerships to monitor and improve the care that survivors receive, ASCO and NCCS are co-chairing the new Cancer Quality Alliance, a forum for diverse stakeholders in the cancer community who will work to improve the quality of the cancer care delivery system. Through this partnership, ASCO, NCCS, and the other members will establish integrated treatment systems to ensure all people with cancer receive the best care possible.

  • New Survivorship Track at ASCO Annual Meeting: ASCO also will provide educational opportunities to healthcare providers on survivorship through sessions in a new “Patient and Survivor Care” track at its Annual Meeting in June 2006. One session in this expanded track will focus on how to write a “Survivorship Prescription,” which will highlight the IOM recommendations for outlining a follow-up care plan. Topics addressed in other sessions will include developing cancer survivorship programs; minimizing long-term consequences of breast cancer therapy; nutrition issues for survivors, and survivorship issues in genitourinary malignancies, among other sessions.

The “Symposium on Cancer Survivorship” is being held Tuesday, November 8, from 8:30 a.m. to 4:30 p.m. at the National Academy of Sciences Building, 2101 Constitution Avenue, NW, Washington, D.C. reporters are invited to attend.

Reporters are also invited to attend a press briefing on Monday, November 7, at 9:30 a.m. in the Holman Lounge of the National Press Club, 529 14th Street NW, Washington, DC, where IOM leaders will discuss the report.

The report is embargoed until 9:30 a.m. EST on November 7. Advanced copies of the IOM report are available to reporters only beginning at 9:00 a.m. EST on Thursday, November 3. Obtain copies of the report by contacting Christine Stencel at 202-334-2138 or by e-mail at; or Erika Borodinsky at 202-955-6222 or by e-mail at

• • •

The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians of all oncology subspecialties who care for people with cancer. ASCO’s more than 20,000 members from the U.S. and abroad set the standard for patient care worldwide and lead the fight for more effective cancer treatments, increased funding for clinical and

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement